Press Releases

CH-Health invests in Galmed; Haim Hurvitz appointed Chairman

Galmed Pharmaceuticals today announced the completion of a $5.5M financing round in the company. The round was led by private Venture Capital firm CH-Health, headed by Mr. Haim Hurvitz, a board member of Teva.  Following the investment, Mr. Hurvitz was appointed Chairman of the Board of Galmed Pharmaceuticals.

In addition, Dr. Maya Halpern, previously a senior executive at Teva and now a medical Advisor at CH-Health, was appointed as Chief Medical Officer at Galmed Pharmaceuticals.